Low-Dose Hydrocortisone/Antifungal Development Urged At FDA Committee
Executive Summary
A half-percent hydrocortisone combined with an antifungal would satisfy an unfulfilled primary-care need for a combination drug to treat skin problems that may or may not be fungal, FDA Dermatologic & Ophthalmologic Drugs Advisory Committee member William Rosenburg, MD, recommended June 29.